174 related articles for article (PubMed ID: 37643636)
1. Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3.
Kaplan HG; Whiteaker JR; Nelson B; Ivey RG; Lorentzen TD; Voytovich U; Zhao L; Corwin DJ; Resta R; Paulovich AG
J Natl Compr Canc Netw; 2023 Aug; 21(11):1110-1116. PubMed ID: 37643636
[TBL] [Abstract][Full Text] [Related]
2. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
Sorscher S; Ansley K; Delaney SD; Ramkissoon S
Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.
Yang C; Sheehan M; Borras E; Cadoo K; Offit K; Zhang L
Fam Cancer; 2020 Oct; 19(4):315-322. PubMed ID: 32356167
[TBL] [Abstract][Full Text] [Related]
4. A novel frameshift mutation in the
Pandey AS; Shrestha S
Indian J Cancer; 2018; 55(4):410-412. PubMed ID: 30829280
[TBL] [Abstract][Full Text] [Related]
5. A Novel Germline
Klančar G; Blatnik A; Šetrajčič Dragoš V; Vogrič V; Stegel V; Blatnik O; Drev P; Gazič B; Krajc M; Novaković S
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32197529
[TBL] [Abstract][Full Text] [Related]
6. Clonal origin and genomic diversity in Lynch syndrome-associated endometrial cancer with multiple synchronous tumors: Identification of the pathogenicity of MLH1 p.L582H.
Takahashi K; Yachida N; Tamura R; Adachi S; Kondo S; Abé T; Umezu H; Nyuzuki H; Okuda S; Nakaoka H; Yoshihara K
Genes Chromosomes Cancer; 2024 Mar; 63(3):e23231. PubMed ID: 38459936
[TBL] [Abstract][Full Text] [Related]
7. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
[TBL] [Abstract][Full Text] [Related]
8. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
9. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
[TBL] [Abstract][Full Text] [Related]
10. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
[No Abstract] [Full Text] [Related]
11. MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.
Kientz C; Prieur F; Clemenson A; Joly MO; Stachowicz ML; Auclair J; Attignon V; Schiappa R; Wang Q
Fam Cancer; 2020 Jan; 19(1):11-14. PubMed ID: 31745674
[TBL] [Abstract][Full Text] [Related]
12. Unique
Serra S; Capo-Chichi JM; McCarthy AJ; Sabatini P; Chetty R
J Clin Pathol; 2020 May; 73(5):291-295. PubMed ID: 31649038
[TBL] [Abstract][Full Text] [Related]
13. Two Cases of Thymic Cancer in Patients with Lynch Syndrome.
Watanabe M; Tanakaya K; Furukawa S; Shiotani T; Sato Y; Taniguchi F; Kanaya N; Aoki H; Sugano K; Ishida H; Akagi K; Kataoka K
Intern Med; 2023 Feb; 62(4):649-653. PubMed ID: 35908972
[TBL] [Abstract][Full Text] [Related]
14. A Chinese family affected by lynch syndrome caused by MLH1 mutation.
Jia S; Zhang M; Sun Y; Yan H; Zhao F; Li Z; Ji J
BMC Med Genet; 2018 Jun; 19(1):106. PubMed ID: 29929473
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.
Schwartz CJ; da Silva EM; Marra A; Gazzo AM; Selenica P; Rai VK; Mandelker D; Pareja F; Misyura M; D'Alfonso TM; Brogi E; Drullinsky P; Razavi P; Robson ME; Drago JZ; Wen HY; Zhang L; Weigelt B; Shia J; Reis-Filho JS; Zhang H
Clin Cancer Res; 2022 Jan; 28(2):404-413. PubMed ID: 34667028
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.
Rosty C; Clendenning M; Walsh MD; Eriksen SV; Southey MC; Winship IM; Macrae FA; Boussioutas A; Poplawski NK; Parry S; Arnold J; Young JP; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; DeRycke M; Lindor NM; Thibodeau SN; Baron JA; Win AK; Hopper JL; Jenkins MA; Buchanan DD;
BMJ Open; 2016 Feb; 6(2):e010293. PubMed ID: 26895986
[TBL] [Abstract][Full Text] [Related]
17. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
[TBL] [Abstract][Full Text] [Related]
18. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
[TBL] [Abstract][Full Text] [Related]
19. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]